China Biologic Products to Participate in the Brean Murray Carret & Co. Boston Healthcare 1x1 Conference
February 25 2010 - 8:00AM
PR Newswire (US)
TAI'AN, China, Feb. 25 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (NASDAQ:CBPO) ("China Biologic," or the
"Company"), a leading plasma-based biopharmaceutical company in
China, today announced that the Company's management team will
attend the upcoming Brean Murray Carret & Co. ("BMC") Boston
Healthcare 1x1 Conference (the "BMC 1x1 Conference"), on March 1,
2010. The BMC 1x1 Conference venue will be The Hilton Boston
Financial District, 89 Broad Street, Boston, MA 02110. China
Biologic's management team will be available for one-on-one
meetings with institutional investors at the conference.
Participation in the BMC Conference is by invitation only.
Interested parties are asked to contact Lindsay Zuckerman at or
call (212) 702-6577. About China Biologic Products, Inc. China
Biologic Products, Inc. (the "Company"), through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its
equity investment in Xi'an Huitian Blood Products Co., Ltd., is
currently the largest non-state- owned plasma-based
biopharmaceutical company in China. The Company is a fully
integrated biologic products company with plasma collection,
production and manufacturing, research and development, and
commercial operations. The Company's plasma-based biopharmaceutical
products are irreplaceable during medical emergencies, and are used
for the prevention and treatment of various diseases. The Company
sells its products to hospitals and other healthcare facilities in
China. For more information, please contact: Company Contact: Mr.
Y. Tristan Kuo Chief Financial Officer China Biologic Products,
Inc. Phone: +86-538-6202206 Email: Web:
http://www.chinabiologic.com/ Investor Relations Contact: Ms. Lei
Huang, Account Manager CCG Investor Relations Phone:
+1-646-833-3417 Email: Web: http://www.ccgirasia.com/ Mr. Crocker
Coulson, President Phone: +1-646-213-1915 Email: DATASOURCE: China
Biologic Products, Inc. CONTACT: Mr. Y. Tristan Kuo, Chief
Financial Officer of China Biologic Products, Inc.,
+86-538-6202206, ; or Investors, Ms. Lei Huang, Account Manager,
+1-646-833-3417, , or Crocker Coulson, President, +1-646-213-1915,
, both of CCG Investor Relations Web Site:
http://www.chinabiologic.com/
Copyright